In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Haemonetics enters $700mm loan agreement

Executive Summary

Haemonetics Corp. (blood management devices and services) entered into a $700mm loan agreement, which includes a $350mm unsecured term loan and a $350mm senior unsecured revolving credit facility. Both loans bear interest at an annual rate of LIBOR plus 1.25% and are due in 2023. Proceeds will be used to repay an existing $254mm senior unsecured term loan due June 2019.
Deal Industry
  • Medical Devices
  • Services
  • Medical Devices
    • Diagnostic Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Nonconvertible Debt
    • Private Placement

Related Companies